AMRX Amneal Pharmaceuticals RESULTS: Q2, Q2 Net Income $58M, Q2 ADJ EPS $0.3 vs. EST $0.22, Q2 REV $796M, Q2 ADJ EBITDA $206M
AMRX Amneal Pharmaceuticals RESULTS: Q2, Q2 Net Income $58M, Q2 ADJ EPS $0.3 vs. EST $0.22, Q2 REV $796M, Q2 ADJ EBITDA $206M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.